Skip to main content
SpringerLink
Log in

Eptacog alfa/factor VIII inhibitor bypassing fraction

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jain S, et al. Successful management of refractory haematuria with recombinant porcine factor VIII replacement for paediatric congenital haemophilia A with high-titre inhibitor. Haemophilia 23: e358-e361, No. 4, Jul 2017. Available from: URL: http://doi.org/10.1111/hae.13240 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eptacog alfa/factor VIII inhibitor bypassing fraction. Reactions Weekly 1669, 124 (2017). https://doi.org/10.1007/s40278-017-36018-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-36018-6

Search

Navigation